Duke Energy Corp vs Heron Therapeutics Inc — how do they compare? Duke Energy Corp trades at $123.3 (market cap $96.05B), while Heron Therapeutics Inc trades at $0.33 (market cap $61.47M). The key difference: Duke Energy Corp is far larger — about 1562.6× Heron Therapeutics Inc's market cap, and Duke Energy Corp pays a 3.52% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| DUK | HRTX | |
|---|---|---|
Market Cap | $96.05B | $61.47M |
Sector | Utilities | Health |
52-Week High | $133.46 | $1.49 |
52-Week Low | $113.99 | $0.32 |
Enterprise Value | $188.56B | $168.21M |
Dividend Yield | 3.52% | — |
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $121.19, down 2.93% on the day, with a bearish technical signal. The company reported strong Q2 2026 earnings of $1.43 per share, beating estimates, and maintains solid fundamentals with a 15.78% net income margin. Recent news highlights operational challenges from storms affecting customers but also strategic initiatives like a $35 million equity units offering and data center growth opportunities.
The outlook is mixed; fundamentals are robust with consistent earnings beats and a healthy dividend, but technical weakness and high debt levels pose risks. Analyst consensus is a 'Hold' with a $136.17 price target, suggesting cautious optimism for long-term investors amid near-term volatility.
HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.
The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.
Trailing returns across standard periods
Latest headlines on both assets
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →